This site is intended for healthcare professionals
News

CHMP recommends approval of Qutavina teriparatide biosimilar for osteoporosis.- EuroGenerics Holdings

Read time: 1 mins
Last updated:29th Jun 2020
Published:28th Jun 2020
Condition: Osteoporosis
Type: drug
Register free for full access to medthority.com